Every day, the people of Memorial Sloan Kettering Cancer Center (MSK) are driven by a singular mission: ending cancer for life. That relentless focus enables us to provide the world’s best, most ...

Memorial Sloan Kettering Cancer Center is proud to announce the formation of MSK Ventures, a dedicated venture capital fund launching in 2026. MSK Ventures is designed to invest in high-conviction ...

The Society of Memorial Sloan-Kettering (MSK) held its 16th Annual Spring Ball on Thursday night, in the freshly redone ballroom of the Pierre Hotel, where 430 guests came out to support this ...

Memorial Sloan Kettering Cancer Center and health insurer Anthem Blue Cross and Blue Shield have reached a deal on payment rates, maintaining coverage of cancer services for thousands of patients in ...

Memorial Sloan Kettering Cancer Center (MSK) and UnitedHealthcare (UHC) today announced a new, multiyear agreement that ensures continued in-network access to MSK for UHC’s commercial members. As a ...

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their ...

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — a hub for basic science and translational research within MSK — discovered ferroptosis regulators ...

Tuesday morning, the nation’s largest insurance company, UnitedHealthcare and Memorial Sloan Kettering Cancer Center announced they had reached a multi-year agreement that will allow some 19,000 ...

At The Society of MSK's Spring Ball, the chic uptown crowd showed up for an unforgettable night of glamour and philanthropy.

AI, comedy, and community unite at MSK’s Spring Ball to drive cancer breakthroughs, raising millions while turning data, ...